Achieving Adherence to Glaucoma Medications: Are We There Yet? healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Needham expects Glaukos Corp (NYSE: GKOS) to surpass expectations and raise outlook in Q2 FY23, fueled by rebounding iStent inject volumes post-2022 reimbursement-driven declines. An additional upside is expected from the accelerating iAccess and iPRIME launches.
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Ocular Surgery News | The volume of minimally invasive glaucoma surgery has increased significantly in recent years, providing an alternative to traditional glaucoma surgeries.Data from various studies demonstrate that MIGS is associated with low risk for adverse events and has beneficial effects on visual field preservation, quality of life and cost-effectiveness among patients with mild to moderate glaucoma.